Precise coding is essential for OBGYN providers to ensure compliance, prevent claim denials, and secure appropriate reimbursement. CPT 57500 is used for diagnostic cervical biopsy, which may include a single or multiple biopsy sites. This procedure is primarily performed to evaluate abnormal Pap smears, HPV positivity, or visually suspicious areas of the cervix.
This guide outlines 2025 coding recommendations, documentation requirements, reimbursement considerations, and modifier use, aligned with AAPC and CMS guidelines, allowing OBGYN practices to code and bill with confidence.
CPT 57500 – Description
Official Definition: “Biopsy of the cervix, single or multiple sites.”
This procedure involves collecting tissue from the cervical epithelium for histopathologic analysis. The physician may use a punch, scalpel, or curette to target specific abnormal areas. CPT 57500 is a diagnostic code and does not include endocervical curettage or loop excision procedures, which are coded separately (CPT codes 57456, 57460, or 57461).
Key distinctions:
- Includes one or more biopsy sites within the cervix.
- Separate codes apply for colposcopy with ECC (57456) or therapeutic loop excision (57460/57461).
- The procedure is typically performed in an office or outpatient setting.
When to Use CPT 57500
CPT 57500 is appropriate when performing a targeted biopsy to evaluate cervical abnormalities. Clinical indications often include:
- Low- or high-grade squamous intraepithelial lesions (LSIL, HSIL).
- Atypical glandular cells (AGC) were detected on cytology.
- Persistent abnormal Pap or positive high-risk HPV tests.
- Visualization of discrete lesions during colposcopy or routine cervical inspection.
- Surveillance of previously treated areas requiring tissue confirmation.
Do not report 57500 if the procedure includes:
- Endocervical curettage (use 57456).
- Loop electrode excision or conization (use 57460/57461).
- Cold-knife conization or larger therapeutic excision (use 57520–57522).
Coding Guidelines and Compliance
Per AAPC and CMS 2025 guidance:
- Report CPT 57500 once per encounter, regardless of the number of biopsy sites.
- The code includes both colposcopic visualization and tissue collection for diagnostic purposes.
- The procedure carries a 10-day global period, encompassing routine post-biopsy visits.
- Documentation must clearly support medical necessity, especially when performed for surveillance or follow-up after prior abnormal results.
- When other unrelated procedures are performed concurrently, verify NCCI edits and apply modifiers only when clinically justified.
Reimbursement Overview
CPT 57500 – 2025 Payment Data
- Global period: 10 days
- Typical setting: Office or outpatient clinic
- Average Medicare reimbursement: $100–$130 (regional variations apply)
- ASC payment: Often bundled with pathology or related procedures
Commercial insurers may require supporting documentation, such as previous Pap results or HPV test outcomes, to establish medical necessity. Pre-authorization may be necessary for certain payers when multiple biopsies are performed.
Modifier Guidance
Accurate modifier use ensures claims are processed correctly:
- Modifier 25: For a significant, separately identifiable E/M service performed the same day.
- Modifier 51: When multiple procedures are performed concurrently.
- Modifier 59 (or XU): To indicate distinct procedural services in addition to unrelated procedures.
- Modifier 26 / TC: Used when separating professional and technical components in facility billing.
Unnecessary modifiers can trigger claim denials or payer audits, so documentation must clearly justify any modifier applied.
Documentation Essentials
Clear, detailed documentation is critical for reimbursement and audit protection. Each cervical biopsy note should include:
- Clinical indication: Abnormal Pap, persistent HPV, or visual lesion.
- Number and location of biopsy sites: Documented precisely for each sample.
- Procedure technique: Instrument used and method of tissue collection.
- Specimen handling: Confirmation that tissue was submitted to pathology.
- Post-procedure follow-up: Instructions and recommended surveillance.
Comprehensive documentation supports the medical necessity of 57500 and ensures audit readiness under CMS 2025 standards.
Example Scenarios
Scenario 1:
A 35-year-old patient with LSIL Pap results undergoes biopsy of a single suspicious area on the cervix. → Report CPT 57500.
Scenario 2:
Multiple abnormal areas are biopsied during colposcopy for high-grade lesions. → Report CPT 57500 (covers single or multiple sites).
Scenario 3:
Loop electrode excision of the transformation zone is performed. → Report CPT 57460 or 57461, not 57500.
BillingFreedom – Leaders in OBGYN Medical Billing
BillingFreedom specializes in OBGYN medical billing, providing expertise in accurate coding, compliance, and reimbursement optimization for procedures like CPT 57500. Our certified coders adhere to AAPC and CMS 2025 standards, ensuring that claims are accurate, audit-ready, and fully compliant.
Through meticulous documentation review, payer-specific coding validation, and revenue cycle optimization, BillingFreedom helps OBGYN practices reduce denials, improve claim acceptance, and focus on patient care. At the same time, we manage the complexities of medical billing.
For more details about our OB/GYN medical billing services, please don't hesitate to contact us via email at info@billingfreedom.com or call us at +1 (855) 415-3472.
Your financial tranquility is our priority!
Related ICD-10-CM Codes
ICD-10-CM Codes
A63.0 - Anogenital (venereal) warts
C53.0 - Malignant neoplasm of endocervix
C53.1 - Malignant neoplasm of exocervix
C53.8 - Malignant neoplasm of overlapping sites of cervix uteri
C53.9 - Malignant neoplasm of cervix uteri, unspecified
D06.0 - Carcinoma in situ of endocervix
D06.1 - Carcinoma in situ of exocervix
D06.7 - Carcinoma in situ of other parts of cervix
D06.9 - Carcinoma in situ of cervix, unspecified
D07.30 - Carcinoma in situ of unspecified female genital organs
D26.0 - Other benign neoplasm of cervix uteri
D28.7 - Benign neoplasm of other specified female genital organs
D49.59 - Neoplasm of unspecified behavior of other genitourinary organ
N72 - Inflammatory disease of cervix uteri
N76.0 - Acute vaginitis
N76.1 - Subacute and chronic vaginitis
N76.2 - Acute vulvitis
N76.3 - Subacute and chronic vulvitis
N81.4 - Uterovaginal prolapse, unspecified
N84.0 - Polyp of corpus uteri
N84.1 - Polyp of cervix uteri
N84.3 - Polyp of vulva
N86 - Erosion and ectropion of cervix uteri
N87.0 - Mild cervical dysplasia
N87.1 - Moderate cervical dysplasia
N87.9 - Dysplasia of cervix uteri, unspecified
N88.0 - Leukoplakia of cervix uteri
N88.1 - Old laceration of cervix uteri
N88.4 - Hypertrophic elongation of cervix uteri
N88.8 - Other specified noninflammatory disorders of cervix uteri
N88.9 - Noninflammatory disorder of cervix uteri, unspecified
N89.8 - Other specified noninflammatory disorders of vagina
N92.6 - Irregular menstruation, unspecified
N93.1 - Pre-pubertal vaginal bleeding
N93.9 - Abnormal uterine and vaginal bleeding, unspecified
N94.89 - Other specified conditions associated with female genital organs and menstrual cycle
N95.0 - Postmenopausal bleeding
N95.2 - Postmenopausal atrophic vaginitis
Q51.0 - Agenesis and aplasia of uterus
Q51.5 - Agenesis and aplasia of cervix
Q51.6 - Embryonic cyst of cervix
Q51.821 - Hypoplasia of cervix
Q51.828 - Other congenital malformations of cervix
Q52.8 - Other specified congenital malformations of female genitalia
R19.00 - Intra-abdominal and pelvic swelling, mass and lump, unspecified site
R68.89 - Other general symptoms and signs
R87.610 - Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)
R87.611 - Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)
R87.619 - Unspecified abnormal cytological findings in specimens from cervix uteri
T81.40XA - Infection following a procedure, unspecified, initial encounter
T81.40XD - Infection following a procedure, unspecified, subsequent encounter
T81.40XS - Infection following a procedure, unspecified, sequela
Z01.411 - Encounter for gynecological examination (general) (routine) with abnormal findings
Z01.419 - Encounter for gynecological examination (general) (routine) without abnormal findings
Z12.4 - Encounter for screening for malignant neoplasm of cervix
Related CPT Codes
CPT Codes
57415 - Complete Billing & Coding Guide for Manipulation Procedures on the Vagina
57420 - Endoscopy/Laparascopy Procedures on the Vagina
57421 - Endoscopy/Laparascopy Procedures on the Vagina
57423 - Endoscopy/Laparascopy Procedures on the Vagina
57454 - Colposcopy with Biopsy and Endocervical Curettage
57455 - Colposcopy with Biopsy of Cervix and Upper/Adjacent Vagina
57456 - Endoscopy Procedures on the Cervix Uteri
57460 - Endoscopy Procedures on the Cervix Uteri
57461 - Billing and Coding Guide for Endoscopy Procedures on the Cervix Uteri